Previous studies have confirmed an association between ER polymorphisms and endometrial cancer, endometriosis, and polycystic ovary syndrome (Kim et al., 2010; Mear et al., 2020; Weiderpass et al., 2000). Here, ESR1 is linked to polycystic ovary syndrome.